Filtrer efter Last updated date SelectEfterFørFrom - To Dato Slutdato Denne uge Denne måned Seneste uge Seneste måned Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Efterlad dette felt tomt Filter Resultater (3800) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Efterlad dette felt tomt European Medicines Agency recommends suspension of marketing authorisations for meprobamate-containing medicines in the European Union 20 januar 2012Press releaseHumanMedicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 January 2012 20 januar 2012NewsHumanMedicines European Medicines Agency recommends approval of new medicine for Cushing's disease 20 januar 2012Press releaseHumanMedicines European Medicines Agency releases guideline on biosimilar interferon beta for public consultation 20 januar 2012NewsHumanBiosimilarsRegulatory and procedural guidanceMedicines European Medicines Agency starts review of Gilenya (fingolimod) 20 januar 2012Press releaseHumanMedicines Committee for Orphan Medicinal Products (COMP) January 2012 highlights 16 januar 2012NewsHumanRare diseases Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 10-12 January 2012 13 januar 2012Press releaseVeterinary Public consultation opens on the revised guideline on the evaluation of human anticancer medicines 11 januar 2012NewsHumanRegulatory and procedural guidance European Medicines Agency starts review of aliskiren-containing medicines following termination of ALTITUDE study 22 december 2011Press releaseHumanMedicines New measures to facilitate conduct of ENCePP studies 22 december 2011News 1 … 257 258 259 260 261 Page 261 of 380 262 263 264 265 … 380
European Medicines Agency recommends suspension of marketing authorisations for meprobamate-containing medicines in the European Union 20 januar 2012Press releaseHumanMedicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 January 2012 20 januar 2012NewsHumanMedicines
European Medicines Agency recommends approval of new medicine for Cushing's disease 20 januar 2012Press releaseHumanMedicines
European Medicines Agency releases guideline on biosimilar interferon beta for public consultation 20 januar 2012NewsHumanBiosimilarsRegulatory and procedural guidanceMedicines
European Medicines Agency starts review of Gilenya (fingolimod) 20 januar 2012Press releaseHumanMedicines
Committee for Orphan Medicinal Products (COMP) January 2012 highlights 16 januar 2012NewsHumanRare diseases
Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 10-12 January 2012 13 januar 2012Press releaseVeterinary
Public consultation opens on the revised guideline on the evaluation of human anticancer medicines 11 januar 2012NewsHumanRegulatory and procedural guidance
European Medicines Agency starts review of aliskiren-containing medicines following termination of ALTITUDE study 22 december 2011Press releaseHumanMedicines